Transdermal delivery of salbutamol sulphate: Formulation and evaluation

References

• Kelly, HW, Murphy S. Beta-adrenergic agonists for acute, severe asthma. Ann. Pharmacother. 1992;26:81–91.
   PubMed Web of Science ®Google Scholar
• Sweetman SC. Martindale: The Complete Drug Reference. 34th ed. London (UK): Pharmaceutical Press; 2005.
   Google Scholar
• Ahrens RC, Smith GD. Albuterol: an adrenergic agent for use in the treatment of asthma pharmacology, pharmacokinetics and clinical use. Pharmacother. 1984;4:105–121.
   PubMed Web of Science ®Google Scholar
• Ranade VV. Drug delivery systems 6. Transdermal drug delivery. J. Clin. Pharmacol. 1991;31:401–418.
   PubMed Web of Science ®Google Scholar
• Modamio P, Lastra CF, Marino EL. A comparative in vitro study of percutaneous penetration of beta-blockers in human skin. Int. J. Pharm. 2000;194:249–259.
   PubMed Web of Science ®Google Scholar
• Ke GM, Wang L, Xue HY, Lu WL, Zhang X, Zhang Q, Guo HY. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children. Biol. Pharm. Bull. 2005;28:305–310.
   PubMed Web of Science ®Google Scholar
• Audet MC, Moreau M, Koltun WD, Waldbaum AS, Shangold G, Fisher AC, Creasy GW. for the ORTHO EVRA/EVRA 004 Study Group. Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs. an oral contraceptive: a randomized controlled trial. JAMA. 2001;285(18):2347–2354.
   PubMed Web of Science ®Google Scholar
• Arora P, Mukherjee B. Design, development, physicochemical, and in-vitro and in-vivo evaluation of transdermal patches containing diclofenac diethylammonium salt. J. Pharm. Sci. 2002;91:2076–2089.
   PubMed Web of Science ®Google Scholar
• Eouani C, Piccerelle Ph, Pinderre P, Bourret E, Joachim J. In-vitro comparative study of buccal mucoadhesive performance of different polymeric films. Eur. J. Pharm. Biopharm. 2001;52:45–55.
   PubMed Web of Science ®Google Scholar
• Ritthidej GC, Phaechamud T, Koizumi T. Moist heat treatment on physicochemical change of chitosan salt films. Int. J. Pharm. 2002;232(1–2):11–22.
   PubMedGoogle Scholar
• Baichwal RW. Advances in Drug Delivery Systems. Bombay, India: MSR Foundation; 1983:136–147.
   Google Scholar
• Lin SY, Chen KS, Chu LR. Organic esters of plasticizers affecting the water absorption, adhesive property, glass transition temperature and plasticizer permanence of Eudragit acrylic films. J. Control. Release. 2000;68(3):343–350.
   PubMedGoogle Scholar
• Donnelly RF, McCarron PA, Zawislak AA, Woolfson AD. Design and physicochemical characterisation of a bioadhesive patch for dose-controlled topical delivery of imiquimod. Int. J. Pharm. 2006;307:318–325.
   PubMed Web of Science ®Google Scholar
• Radebaugh GW. Film coatings and film forming materials: Evaluation. In: Swarbrick J, Boylan JC, ed. Encyclopedia of Pharmaceutical Technology. Vol. 6. New York and Basel: Marcel Dekker; 1992.
   Google Scholar
• Martin A. Physical Pharmacy: Physical and Chemical Principles of Pharmaceutical Sciences. 4th ed. Philadelphia: Lea and Febiger; 1993:575–578.
   Google Scholar
• Azarmi S, Roa W, Löbenberg R. Current perspectives in dissolution testing of conventional and novel dosage forms. Int. J. Pharm. 2007;328(1):12–21.
   PubMedGoogle Scholar
• Guide for the Care and Use of Laboratory Animals, #86–23. Bethesda, MD: National Institutes of Health; 1985.
   Google Scholar
• Nicoli S, Penna E, Padula C, Colombo P, Santi P. New transdermal bioadhesive film containing oxybutynin: in-vitro permeation across rabbit ear skin. Int. J. Pharm. 2006;325(1–2):2–7.
   PubMedGoogle Scholar
• Babu RJ, Pandit JK. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems. Int. J Pharm. 2005;288(2):325–334.
   PubMedGoogle Scholar
• Williams AC. Transdermal and Topical Drug Delivery. London (UK): Pharmaceutical Press; 2003.
   Google Scholar
• Williams AC, Barry BW. Penetration enhancers. Adv. Drug. Deliv. Rev. 2004;56(5):603–618.
   PubMed Web of Science ®Google Scholar
• Sutariya VB, Mashru RC, Sankalia MG, Sankalia JM. Liquid chromatographic determination and pharmacokinetics study of salbutamol sulphate in rabbit plasma. Ars. Pharm. 2006;47(2):185–197.
   Google Scholar
• Saha P, Kim KJ, Yamahara H, Crandall ED, Lee VHL. Influence of lipophilicity on beta-blocker permeation across rat alveolar epithelial cell monolayers. J. Control Release. 1994;32:191–200.
   Web of Science ®Google Scholar
• Tojo K, Chiang CC, Chien YW. Drug permeation across the skin: effect of penetrant hydrophilicity. J. Pharm. Sci. 1987;76(2):123–126.
   PubMedGoogle Scholar
• Williams AC, Barry BW. Essential oils as novel human skin penetration enhancers. Int. J. Pharm. 1989;57:R7–9.
   Web of Science ®Google Scholar
• Egyptian guidelines for asthma management. The Egyptian Society of Chest Diseases and Tuberculosis. Egypt J. Chest Dis. Tubercul. 1999;42(suppl. 2):1–37.
   Google Scholar
• The Pharmacopoeia of the United States of America 27, The National Formulary 22. Asian Ed. Pharmacopoeial Convention, Inc., Rockville, MD, U.S.A. 2004:454–458.
   Google Scholar
• Clearly GW. Transdermal controlled release systems. In: LangerRS, Wise DS, eds. Medical Applications of Controlled Release. Vol. 1. Boca Raton, FL: CRC Press; 1984:204–251.
   Google Scholar
• Lim LY, Wan LSC. The effect of plasticizers on the properties of polyvinyl alcohol films. Drug. Dev. Ind. Pharm. 1994;20(6):1007–1020.
   Google Scholar
• Gander B, Gurny R, Doelker E. Pharmaceutical Technology: Controlled Drug Release. Rubinstein MH, ed. Vol. 1. Ellis Horwood Series. New York: Wiley and Sons; 1987:34.
   Google Scholar
• Lim LY, Wan LSC. Combined effects of heat treatment and plasticizers on polyvinyl alcohol films. Drug. Dev. Ind. Pharm. 1995;21:369–373.
   PubMed Web of Science ®Google Scholar
• Rowe RC, Sheskey PJ, Weller PJ. Handbook of Pharmaceutical Exipients. 4th ed. Pharmaceutical Press, London and Chicago: American Pharmaceutical Association; 2003.
   Google Scholar
• Lin SY, Lee CJ, Lin YY. The effect of plasticizers on compatibility, mechanical properties, and adhesion strength of drug-free Eudragit E films. Pharm. Res. 1991;8(9):1137–1143.
   PubMedGoogle Scholar
• Guyot M, Fawaz F. Design and in-vitro evaluation of adhesive matrix for transdermal delivery of propranolol. Int. J. Pharm. 2000;204(1–2):171–182.
   PubMedGoogle Scholar
• Shah VP, Tymes NW, Yamamoto LA, Skelly JP. In-vitro dissolution profile of transdermal nitroglycerin patches using paddle method. Int. J. Pharm. 1986;32(2–3):243–250.
   Google Scholar
• O’Neill CT, Deasy PB. Development and evaluation using hairless mouse skin of a transdermal timolol product. Int. J. Pharm. 1988;48:247–254.
   Google Scholar
• Cevc G, Blume G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers. Bioch. Biophys. Acta. 2001;1514(2):191–205.
   PubMed Web of Science ®Google Scholar
• Ongpipattanakul B, Burnette RR, Potts RO, Francoeur ML. Evidence that oleic acid exists in a separate phase within stratum corneum lipids. Pharm. Res. 1991;8(3):350–354.
   PubMedGoogle Scholar
• Tanojo H, BosvanGeest A, Bouwstra JA, Junginger HE, Bodde HE. In-vitro human skin barrier perturbation by oleic acid: thermal analysis and freeze fracture electron microscopy studies. Thermochim. Acta. 1997;293:77–85.
   Web of Science ®Google Scholar
• Southwell D, Barry BW. Penetration enhancers for human skin: mode of action of 2-pyrrolidone and dimethylformamide on partition and diffusion of model compounds water, n-alcohols and caffeine. J. Invest. Dermatol. 1983;80:507–515.
   PubMed Web of Science ®Google Scholar